Multiple primary cancers (MPC) in a series of lung cancer (LC) patient: Incidence and outcome
Cedres Perez, S., Sanso, M., Hernando-Calvo, A., Callejo, A., Pardo Aranda, N., Navarro Mendivil, A., Martinez, A., Remon, J., Miquel, J.M., Rodriguez, G., Monton, V., Villacampa, G., Dienstmann, R., Vivancos, A., Felip Font, E.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
Refining criteria of hyperprogression (HPD) with immune checkpoint inhibitors (ICIs) to improve clinical applicability
Matos Garcia, I., García Ruiz, A., Martin-Liberal, J., Hierro, C., Ochoa De Olza Amat, M., Viaplana, C., Mur, G., Vieito Villar, M., Brana, I., Azaro, A., Perez, C., Rodriguez Freixinos, V., Argiles, G., Oliveira, M., Felip Font, E., Muñoz-Couselo, E., Tabernero, J., Dienstmann, R., Garralda, E.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
Homology-directed repair (HDR)-defective lung adenocarcinomas (LUACs) in circulating tumor DNA (ctDNA)
Karachaliou, N., Lefterova, M., Draper, J.F., Molina, M.-A., Chaib, I., Palmero, R., Taus, A., Viteri, S., González Cao, M., Majem Tarruella, M., Carcereny Costa, E., Moran, T., Garde Noguera, J., Felip Font, E., Olsen, S., Jackson, M., Sampayo, M., Faull, I., Dix, D., Rosell, R.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
6ER-021 Evaluation of COVID mortality during hospital admission in patients receiving oncological treatment
Serramontmany Morante, E, Cardona-Pascual, I, Garcia Ortega, P, Carreras Soler, M, Gorgas Torner, MQ, Cidoncha Muñoz, I, Felip Font, E
Published in European journal of hospital pharmacy. Science and practice (23.03.2022)
Published in European journal of hospital pharmacy. Science and practice (23.03.2022)
Get full text
Journal Article
127 Correlation of clinical activity of pembrolizumab (MK-3475) with immunohistochemical staining for programmed death-1 ligand (PD-L1) in ≥50% of tumor cells in a prospective non-small cell lung cancer (NSCLC) validation population
Garon, E.G, Rizvi, N.A, Leighl, N.B, Hui, R, Eder, J.P, Patnaik, A, Aggarwal, C, Horn, L, Balmanoukian, A.S, Gubens, M.A, Felip-Font, E, Costa, E. Carceny, Soria, J.C, Ahn, M.J, Arkenau, H.T, Lee, J.S, Robinet, G, Lubiniecki, G.M, Zhang, J, Emancipator, K, Rutledge, R, Dolled-Filhart, M, Gandhi, L
Published in European journal of cancer (1990) (01.11.2014)
Published in European journal of cancer (1990) (01.11.2014)
Get full text
Journal Article
160P Pembrolizumab re-challenge in patients with relapsed non-small cell lung cancer (NSCLC): A preliminary report of the REPLAY phase II trial - cohort I
Ponce Aix, S., Carcereny Costa, E., Bosch-Barrera, J., Felip Font, E., Guirado, M., Coves Sarto, J., Majem Tarruella, M., Juan Vidal, O.J., Dalmau Portulas, E., Diz, P., Ortega Granados, A.L.O., Domine Gomez, M., Blasco Cordellat, A., Mosquera Martinez, J., Sala Gonzalez, M.A., Dorta, M., Calvo de Juan, V., Zugazagoitia, J., Enguita, A.B., Paz-Ares, L.
Published in Annals of oncology (01.12.2021)
Published in Annals of oncology (01.12.2021)
Get full text
Journal Article
Preliminary efficacy and safety of lorlatinib in patients (Pts) with ROS1-positive non-small cell lung cancer (NSCLC)
Besse, B., Shaw, A.T., Solomon, B.J., Bauer, T.M., Chiari, R., Lin, C-C., Satouchi, M., Clancy, J.S., James, L.P., Abbattista, A., Felip Font, E.
Published in Annals of oncology (01.09.2017)
Published in Annals of oncology (01.09.2017)
Get full text
Journal Article
Prospective comparison of liquid biopsy to standard of care tissue testing in metastatic, non-squamous, non-small cell lung cancer (NSCLC) patients (pts)
Palmero, R., Taus, Á., Majem Tarruella, M., Viteri, S., Carcereny Costa, E., Garde, J., Felip Font, E., Cassidy, C., Dix, D., Karachaliou, N., Rosell, R.
Published in Annals of oncology (01.09.2017)
Published in Annals of oncology (01.09.2017)
Get full text
Journal Article
Efficacy and safety of lorlatinib in patients (pts) with ALK+ non-small cell lung cancer (NSCLC) previously treated with 2nd-generation ALK TKIs
Felip Font, E., Shaw, A.T., Solomon, B.J., Bauer, T.M., Ou, S.-H.I., Gadgeel, S., Soo, R.A., Seto, T., Clancy, J.S., James, L.P., Abbattista, A., Besse, B.
Published in Annals of oncology (01.09.2017)
Published in Annals of oncology (01.09.2017)
Get full text
Journal Article
103P First-line avelumab in combination with cetuximab and chemotherapy in patients with advanced squamous non-small cell lung cancer (NSCLC)
Andric, Z.G., Gálffy, G., Dols, M. Cobo, Szima, B., Stojanovic, G., Petrovic, M.D., Font, E. Felip, Baz, D. Vicente, Aix, S. Ponce, Juan-Vidal, O., Tehenes, S., Szalai, Z., Losonczy, G., Blanco, A. Calles, Bernabe, R., Duecker, K., Zhou, D., Schroeder, A., Guezel, G., Ciardiello, F.
Published in Journal of thoracic oncology (01.04.2021)
Published in Journal of thoracic oncology (01.04.2021)
Get full text
Journal Article
1806PDMultiple primary cancers (MPC) in a series of lung cancer (LC) patient: Incidence and outcome
Cedres Perez, S, Sanso, M, Hernando-Calvo, A, Callejo, A, Pardo Aranda, N, Navarro Mendivil, A, Martinez, A, Remon, J, Miquel, J M, Rodriguez, G, Monton, V, Villacampa, G, Dienstmann, R, Vivancos, A, Felip Font, E
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
1490PDA phase Ia/IIa trial of Sym015, a MET antibody mixture, in patients with advanced solid tumours
Camidge, D R, Janku, F, Bueno, A Martinez, Catenacci, D V, Lee, J, Lee, S-H, Chung, H C, Dowlati, A, Rohrberg, K S, Felip Font, E, Garralda, E, Kang, Y-K, Moon, Y W, López Criado, M, Chiu, C-F, Poulsen, T T, Rudbæk, H, Alifrangis, L, Dalal, R P, Patnaik, A
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
1490PD - A phase Ia/IIa trial of Sym015, a MET antibody mixture, in patients with advanced solid tumours
Camidge, D.R., Janku, F., Bueno, A Martinez, Catenacci, D.V., Lee, J., Lee, S.-H., Chung, H.C., Dowlati, A., Rohrberg, K.S., Felip Font, E., Garralda, E., Kang, Y.-K., Moon, Y.W., López Criado, M., Chiu, C.-F., Poulsen, T.T., Rudbæk, H., Alifrangis, L., Dalal, R.P., Patnaik, A.
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
A phase Ia/IIa trial of Sym015, a MET antibody mixture, in patients with advanced solid tumours
Camidge, D.R., Janku, F., Bueno, A Martinez, Catenacci, D.V., Lee, J., Lee, S.-H., Chung, H.C., Dowlati, A., Rohrberg, K.S., Felip Font, E., Garralda, E., Kang, Y.-K., Moon, Y.W., López Criado, M., Chiu, C.-F., Poulsen, T.T., Rudbæk, H., Alifrangis, L., Dalal, R.P., Patnaik, A.
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
219P Outcomes of malignant pleural mesothelioma (MPM) patients (p) treated after first line chemotherapy (CT)
Cedres, S., Amair, F., Martinez-Marti, A., Navarro, A., Pardo, N., Remon-Masip, J., Miquel, J.M., Villacampa, G., Dienstmann, R., Font, E. Felip
Published in Journal of thoracic oncology (01.04.2018)
Published in Journal of thoracic oncology (01.04.2018)
Get full text
Journal Article
Outcomes of malignant pleural mesothelioma (MPM) patients (p) treated with immune-oncology drugs (IO) in clinical trials
Cedres, S., Martinez Marti, A., Navarro, A., Pardo, N., Remon, J., Matos, I., Ochoa de Olza, M., Hierro, C., Martin Liberal, J., Miquel, J.M., Viaplana, C., Villacampa Javierre, G., Dienstmann, R., Felip Font, E.
Published in Annals of oncology (01.09.2017)
Published in Annals of oncology (01.09.2017)
Get full text
Journal Article
Major pathological response after preoperative chemotherapy as a surrogate marker of survival in early-stage non-small cell lung cancer: cohort of NATCH phase III trial
Remon, J., Martinez-Marti, A., Carcereny Costa, E., Zeron-Medina Cuairan, J., Sansano, I., Mate, J.L., Pardo, N., Cedres, S., Navarro, A., Martinez de castro, A.M., Moran, T., Felip Font, E.
Published in Annals of oncology (01.09.2017)
Published in Annals of oncology (01.09.2017)
Get full text
Journal Article
1841PRefining criteria of hyperprogression (HPD) with immune checkpoint inhibitors (ICIs) to improve clinical applicability
Matos Garcia, I, García Ruiz, A, Martin-Liberal, J, Hierro, C, Ochoa De Olza Amat, M, Viaplana, C, Mur, G, Vieito Villar, M, Brana, I, Azaro, A, Perez, C, Rodriguez Freixinos, V, Argiles, G, Oliveira, M, Felip Font, E, Muñoz-Couselo, E, Tabernero, J, Dienstmann, R, Garralda, E
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
1895PDHomology-directed repair (HDR)-defective lung adenocarcinomas (LUACs) in circulating tumor DNA (ctDNA)
Karachaliou, N, Lefterova, M, Draper, J F, Molina, M-A, Chaib, I, Palmero, R, Taus, A, Viteri, S, González Cao, M, Majem Tarruella, M, Carcereny Costa, E, Moran, T, Garde Noguera, J, Felip Font, E, Olsen, S, Jackson, M, Sampayo, M, Faull, I, Dix, D, Rosell, R
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
Three-year follow-up from CheckMate 017/057: Nivolumab versus docetaxel in patients with previously treated advanced non-small cell lung cancer (NSCLC)
Felip Font, E., Gettinger, S.N., Burgio, M.A., Antonia, S.J., Holgado, E., Spigel, D.R., Arrieta, O., Domine Gomez, M., Aren Frontera, O., Brahmer, J., Chow, L.Q., Crinò, L., Butts, C., Coudert, B., Horn, L., Steins, M., Geese, W.J., Li, A., Healey, D., Vokes, E.E.
Published in Annals of oncology (01.09.2017)
Published in Annals of oncology (01.09.2017)
Get full text
Journal Article